Login / Signup
Meng Maxine Tong
ORCID
Publication Activity (10 Years)
Years Active: 2022-2023
Publications (10 Years): 4
Top Topics
Acute Lymphoblastic Leukemia
Mouse Model
Epidermal Growth Factor Receptor
Pi K Akt
Top Venues
Clinical cancer research : an official journal of the American Association for Cancer Research
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Lindsay M Gurska
,
Rachel Okabe
,
Alexandra Schurer
,
Meng Maxine Tong
,
Mark Soto
,
Daniel C Choi
,
Kristina Ames
,
Shira G Glushakow-Smith
,
Allison Montoya
,
Ellen Tein
,
Linde A Miles
,
Haiying Cheng
,
Pamela A Hankey-Giblin
,
Ross L Levine
,
Swati Goel
,
Balazs Halmos
,
Kira Gritsman
Crizotinib Has Preclinical Efficacy in Philadelphia-Negative Myeloproliferative Neoplasms.
Clinical cancer research : an official journal of the American Association for Cancer Research
29 (5) (2023)
Lindsay M Gurska
,
Rachel Okabe
,
Alexandra Schurer
,
Meng Maxine Tong
,
Mark Soto
,
Daniel C Choi
,
Kristina Ames
,
Shira G Glushakow-Smith
,
Allison Montoya
,
Ellen Tein
,
Linde A Miles
,
Haiying Cheng
,
Pamela A Hankey-Giblin
,
Ross L Levine
,
Swati Goel
,
Balazs Halmos
,
Kira Gritsman
Crizotinib Has Preclinical Efficacy in Philadelphia-Negative Myeloproliferative Neoplasms.
Clinical cancer research : an official journal of the American Association for Cancer Research
29 (5) (2023)
Lindsay M Gurska
,
Rachel Okabe
,
Alexandra Schurer
,
Meng Maxine Tong
,
Mark Soto
,
Daniel C Choi
,
Kristina Ames
,
Shira G Glushakow-Smith
,
Allison Montoya
,
Ellen Tein
,
Linde A Miles
,
Haiying Cheng
,
Pamela A Hankey-Giblin
,
Ross L Levine
,
Swati Goel
,
Balazs Halmos
,
Kira Gritsman
Crizotinib Has Preclinical Efficacy in Philadelphia-Negative Myeloproliferative Neoplasms.
Clinical cancer research : an official journal of the American Association for Cancer Research
29 (5) (2023)
Lindsay M Gurska
,
Rachel Okabe
,
Alexandra Schurer
,
Meng Maxine Tong
,
Mark Soto
,
Daniel C Choi
,
Kristina Ames
,
Shira G Glushakow-Smith
,
Allison Montoya
,
Ellen Tein
,
Linde A Miles
,
Haiying Cheng
,
Pamela A Hankey-Giblin
,
Ross L Levine
,
Swati Goel
,
Balazs Halmos
,
Kira Gritsman
Crizotinib has Preclinical Efficacy in Philadelphia-negative Myeloproliferative Neoplasms.
Clinical cancer research : an official journal of the American Association for Cancer Research
(2022)